ArticleJournal of family & reproductive health2025
Serum 25-Hydroxyvitamin D and Sperm DNA Fragmentation Index In Men Referred For Infertility: A Cross-Sectional Study of 783 Patients.
Article in Journal of family & reproductive health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To evaluate the association between serum 25-hydroxyvitamin D [25(OH)D] concentration and sperm DNA fragmentation index (DFI), and to identify clinical predictors of elevated DFI among men referred for infertility. Materials and methods: We conducted a cross-sectional study of 783 men referred to a tertiary infertility clinic. Participants underwent semen analysis according to WHO criteria, measurement of serum 25(OH)D by standard immunoassay, and assessment of sperm DNA fragmentation using a validated laboratory method. Demographic and clinical variables (age, BMI, smoking, duration of infertility) were recorded. Associations between 25(OH)D and DFI were evaluated using correlation analysis and multivariable linear and logistic regression models adjusted for potential confounders. Elevated DFI was predefined based on laboratory cutoffs. Results: Among 783 men, vitamin D deficiency was common and a wide range of DFI values was observed. Serum 25(OH)D concentration showed no significant association with sperm DFI after adjustment for age and conventional semen parameters (adjusted effect estimates not significant). In multivariable analyses, older age, lower progressive motility, abnormal morphology and reduced sperm concentration were independently associated with higher DFI (all p < 0.05). These associations persisted when DFI was analyzed as a dichotomous outcome (elevated vs. normal). Conclusion: In this large clinic-based sample, serum 25(OH)D was not independently associated with sperm DNA fragmentation. Conventional semen quality measures and age were stronger and consistent predictors of elevated DFI. These findings suggest that routine assessment of vitamin D status is unlikely to inform sperm DNA integrity beyond established semen parameters; prospective studies are needed to confirm causality.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.